Vidasym, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.vidasym.com
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of VS 105
Phase 1
Completed
- Conditions
- Chronic-kidney Disease Stage 5D on Stable Hemodialysis
- Interventions
- Drug: Single VS-105/placebo to healthyDrug: Multiple VS-105/placebo to healthyDrug: Multiple VS-105/placebo to HD subjects
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2019-10-07
- Lead Sponsor
- Vidasym, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT03043482
- Locations
- 🇺🇸
DaVita Clinical Research, Lakewood, Colorado, United States
© Copyright 2025. All Rights Reserved by MedPath